COMPANY PROFILE

House Rx

Explore full profile

Health technology platform focused on improving affordability and patient access to specialty medications

San Francisco, United StatesFounded 2020Health Tech & Medtech

Valuation $100–250M Last recorded · 2025

Revenue $10–50M Latest reported FY

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About House Rx

HouseRx is a healthcare startup that operates in the specialty medication management sector. The company's primary offering is a shared platform that connects Electronic Health Record (EHR) and pharmacy management systems, allowing physicians and pharmacists to collaborate more effectively on patient care. This platform is designed to reduce the administrative burden associated with specialty medication prescribing, increase income for medical practices, and provide patients with a faster, more convenient, and cost-effective way to access their medications.

Read full description

HouseRx's business model revolves around providing a service that ensures patients not only start their therapy but also continue it. This is achieved by working closely with doctors to find alternative prescriptions for patients who can't afford their medication, as well as adjusting dosages based on individual health conditions to ensure safety and effectiveness of treatment. The company's built-in analytics also allow for monitoring and influencing operational efficiency and quality of care.

HouseRx's clients are primarily healthcare providers, such as Marin Cancer Care, who use the platform to streamline their medication dispensing process. However, the ultimate beneficiaries of the service are the patients, who receive personalized care and support in managing their specialty medication needs.

The startup operates in the broader healthcare technology market, which is seeing increasing demand for solutions that improve efficiency, reduce costs, and enhance patient care.

Source: Dealroom company data